Jubilant Cadista Pharmaceuticals, Inc. FDA Record
- Latest inspection VAI · Jan 15, 2025
- 2 Class I recalls
- No warning letters matched by name
Jubilant Cadista Pharmaceuticals, Inc. has 31 FDA recalls (2 Class I), 9 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Jubilant Cadista Pharmaceuticals, Inc." is on file.
- Latest recall
- D-0096-2023 · Class III · Dec 27, 2022
- Latest inspection
- Jan 15, 2025 · VAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 31 (2 Class I) | Nov 11, 2026 (checked Nov 15, 2026, unchanged) | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 0 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 9 | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions | 0 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
Jubilant Cadista Pharmaceuticals, Inc.: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 1 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 5 | 1 |
| 2021 | 0 | 0 | 0 | 3 | 0 |
| 2020 | 1 | 0 | 0 | 4 | 0 |
| 2019 | 0 | 0 | 0 | 5 | 1 |
| 2018 | 1 | 0 | 0 | 7 | 0 |
| 2017 | 0 | 0 | 0 | 1 | 0 |
Reviewing Jubilant Cadista Pharmaceuticals, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Jubilant Cadista Pharmaceuticals, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0096-2023 | Class III | Prochlorperazine Maleate Tablets, USP 5mg, 100 tablets, RX Only, Jubilant Cadista Pharmaceuticals… | Dec 27, 2022 |
| D-1294-2022 | Class II | Irbesartan Tablets, USP, 75 mg, 90- count bottle, Rx only, Manufactured by: Jubilant Generics Ltd… | Jul 18, 2022 |
| D-1293-2022 | Class II | Irbesartan Tablets, USP, 150mg, 90- count bottles, Rx only, Manufactured by: Jubilant Generics Ltd… | Jul 18, 2022 |
| D-0752-2022 | Class III | Methylprednisolone Tablets, USP 4mg, 100-count bottle, Rx Only, Manufactured by: Jubliant Cadista… | Apr 1, 2022 |
| D-0767-2022 | Class I | Meclizine Hydrochloride Tablets USP, 12.5 mg, packaged in a case of 24 bottles (100-count bottle)… | Mar 8, 2022 |
| D-0784-2021 | Class III | Donepezil HCL Tablets, USP, 5 mg, 90-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd… | Aug 20, 2021 |
| D-0333-2021 | Class II | Itraconazole Capsules, 100 mg, 30-count bottles, Rx only, Manufactured by: Jubilant Generics Ltd… | Apr 1, 2021 |
| D-0298-2021 | Class III | Methylprednisolone Tablets USP, 4 MG, packaged in a 21-count blister pack, Rx only, Jubilant Cadista… | Feb 19, 2021 |
| D-0104-2021 | Class II | clomiPRAMINE Hydrochloride Capsules USP, 50 mg, 30-count bottle, Rx Only, Manufactured by: Jubilant… | Nov 6, 2020 |
| D-0066-2021 | Class III | Olanzapine Orally Disintegrating Tablets, 5 mg, 30 count (3x10 unit dose) blister pack, Rx only… | Oct 26, 2020 |
| D-1281-2020 | Class III | Lamotrigine Tablets, USP, 150 mg, 20,000-count bulk container, Manufactured by: Jubilant Cadista… | May 26, 2020 |
| D-1058-2020 | Class II | Pantoprazole Sodium Delayed-Release Tablets, USP, 40 mg, 90 count bottle, Rx Only, Manufactured by… | Mar 11, 2020 |
| D-0576-2020 | Class II | Amantadine Hydrochloride Tablets, 100 mg, 100-count bottle, Rx only, Manufactured by: Jubilant… | Dec 2, 2019 |
| D-0145-2020 | Class II | Pantoprazole Sodium Delayed Release Tablets, USP, 40 mg, packaged in 90-count bottle, Rx only… | Sep 4, 2019 |
| D-1837-2019 | Class I | Drospirenone and Ethinyl Estradiol Tablets, USP, 3 mg/0.02 mg, packaged into a carton containing 3… | Jul 9, 2019 |
| D-1074-2019 | Class II | Pantoprazole Sodium Delayed-Release Tablets, USP, 40 mg*, 90-count bottle, Rx Only, Manufactured by… | Mar 29, 2019 |
| D-0519-2019 | Class III | BuPROPion Hydrochloride Extended-Release Tablets, USP (XL) 150 mg, a) 30 count (NDC 59746- 758-30) &… | Feb 28, 2019 |
| D-0011-2019 | Class II | Pantoprazole Sodium Delayed-Release Tablets, USP, 40 mg*, 90-count bottle, Rx only, Manufactured by… | Oct 2, 2018 |
| D-1205-2018 | Class III | MethylPREDNISolone Tablets, USP, 4 mg, 21-count blister pack. Rx Only. Jubilant Cadista… | Aug 27, 2018 |
| D-1103-2018 | Class III | Valsartan Tablets USP, 40 mg, 30-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd… | Aug 14, 2018 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Jan 15, 2025 | Yardley, PA | Drugs | Voluntary Action Indicated (VAI) | 3017221809 |
| Feb 28, 2020 | Yardley, PA | Drugs | Voluntary Action Indicated (VAI) | 3017221809 |
| May 4, 2018 | Yardley, PA | Drugs | No Action Indicated (NAI) | 3017221809 |
| Aug 7, 2015 | Yardley, PA | Drugs | Voluntary Action Indicated (VAI) | 3017221809 |
| Jul 8, 2014 | Yardley, PA | Drugs | No Action Indicated (NAI) | 3017221809 |
| Aug 1, 2013 | Yardley, PA | Drugs | No Action Indicated (NAI) | 3017221809 |
| Apr 5, 2012 | Yardley, PA | Drugs | Voluntary Action Indicated (VAI) | 3017221809 |
| Mar 23, 2011 | Yardley, PA | Drugs | Voluntary Action Indicated (VAI) | 3017221809 |
| Oct 29, 2009 | Yardley, PA | Drugs | Voluntary Action Indicated (VAI) | 3017221809 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3017221809 | Yardley, PA | 9 | Jan 15, 2025 |
Jubilant Cadista Pharmaceuticals, Inc. and the FDA: common questions
Has Jubilant Cadista Pharmaceuticals, Inc. received an FDA warning letter?
No FDA warning letter addressed to the name "Jubilant Cadista Pharmaceuticals, Inc." is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has Jubilant Cadista Pharmaceuticals, Inc. received an FDA Form 483?
FDA has not published a Form 483 for "Jubilant Cadista Pharmaceuticals, Inc." in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Jubilant Cadista Pharmaceuticals, Inc.?
The most recent FDA inspection on file ended Jan 15, 2025 at Yardley, PA and was classified VAI. FDA has 9 inspections of Jubilant Cadista Pharmaceuticals, Inc. on file.
Has Jubilant Cadista Pharmaceuticals, Inc. had an FDA recall?
Yes. Jubilant Cadista Pharmaceuticals, Inc. has 31 FDA recalls on record, 2 of them Class I, the most serious class. The most recent started Dec 27, 2022.
Need more than this page shows? Ask about Jubilant Cadista Pharmaceuticals, Inc. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.